Axe Compute Inc.

簡介

本頁面提供了有關 Schwartz Carl I. 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Schwartz Carl I.已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:POAI / Predictive Oncology Inc. 1,711,742
US:SGLB / Sigma Labs Inc 38,835
如何解讀這些圖表

以下圖表顯示了在Schwartz Carl I.進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

AGPU / Axe Compute Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 AGPU / Axe Compute Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2019-05-24 AIPT Schwartz Carl I. 48,332 0.5522 48,332 0.5522 26,689 166 4.6600 198,539 743.93
2019-05-23 AIPT Schwartz Carl I. 51,668 0.5632 51,668 0.5632 29,099
2019-01-08 AIPT Schwartz Carl I. 78,125 0.6400 78,125 0.6400 50,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AGPU / Axe Compute Inc. Insider Trades
AGPU / Axe Compute Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 AGPU / Axe Compute Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AGPU / Axe Compute Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Schwartz Carl I. 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2021-03-30 2021-02-24 4/A POAI Predictive Oncology Inc.
Common Stock
A - Award 100,401 1,711,742 6.23 1.43 143,573 2,447,791
2021-03-12 2021-02-24 4 POAI Predictive Oncology Inc.
Common Stock
J - Other 100,401 1,711,742 6.23 1.43 143,573 2,447,791
2021-02-11 2020-01-28 5 SGLB SIGMA LABS, INC.
Warrants to Purchase Common Stock
P - Purchase 38,835 38,835
2021-02-11 2020-01-28 5 SGLB SIGMA LABS, INC.
Series E Convertible Preferred Stock
P - Purchase 267 267 1,500.00 400,005 400,005
2021-01-05 2020-12-31 4 POAI Predictive Oncology Inc.
Stock Options (right to buy)
A - Award 20,481 20,481
2020-10-26 2020-10-22 4 POAI Predictive Oncology Inc.
Common Stock
S - Sale X -640 1,611,341 -0.04 0.85 -544 1,369,640
2020-10-02 2020-09-30 4 POAI Predictive Oncology Inc.
Stock Options (right to buy)
A - Award 6,142 6,142
2020-09-25 2020-09-23 4 POAI Predictive Oncology Inc.
Restricted Stock Units
A - Award 300,000 300,000
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 6,050 6,050
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -6,050 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 5,128 5,128
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -5,128 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 4,219 4,219
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -4,219 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 20,000 20,000
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -20,000 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 59 59
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -59 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 133 133
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -133 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 121 121
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -121 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 179 179
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -179 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 238 238
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -238 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 7 7
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -7 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 32,305 32,305
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -32,305 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 4,490 4,490
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -4,490 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Common Stock (Right to buy)
A - Award 12,168 12,168
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -12,168 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 14,178 14,178
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -14,178 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 2,834 2,834
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -2,834 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Common Stock (Right to buy)
A - Award 37,691 37,691
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -37,691 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 714 714
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
D - Sale to Issuer -714 0 -100.00
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (Right to buy)
A - Award 52 52
2020-09-09 2020-09-04 4 POAI Predictive Oncology Inc.
Stock Options (right to buy)
D - Sale to Issuer -52 0 -100.00
2020-07-02 2020-06-30 4 POAI Predictive Oncology Inc.
Stock Options (right to buy)
A - Award 3,049 3,049
2020-06-19 2020-06-17 4 POAI Predictive Oncology Inc.
Common Stock
A - Award 4,070 1,611,981 0.25
2020-04-23 2020-04-21 4 POAI Predictive Oncology Inc.
Common Stock
A - Award 1,533,481 1,607,911 2,060.30 1.43 2,192,878 2,299,313
2020-04-06 2020-03-31 4 POAI Predictive Oncology Inc.
Stock Options (right to buy)
A - Award 3,174 3,174
2020-02-04 2020-01-31 4 POAI Predictive Oncology Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other -119,442 0 -100.00
2020-02-04 2020-01-31 4 POAI Predictive Oncology Inc.
Common Stock
J - Other 50,000 74,430 204.67
2019-10-03 2019-10-01 4 POAI Predictive Oncology Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 11,506 1,205,923 0.96
2019-10-03 2019-09-01 4 POAI Predictive Oncology Inc.
Stock Option
A - Award 60,496 60,496
2019-10-03 2019-09-01 4 POAI Predictive Oncology Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 11,506 1,194,417 0.97
2019-09-18 2019-09-01 4 POAI Predictive Oncology Inc.
Stock Option
A - Award 60,496 60,496
2019-09-18 2019-09-01 4 POAI Predictive Oncology Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 11,506 1,194,417 0.97
2019-09-18 2019-08-01 4/A POAI Predictive Oncology Inc.
Stock Option
A - Award 51,282 51,282
2019-09-18 2019-08-01 4/A POAI Predictive Oncology Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 11,506 1,182,911 0.98
2019-09-18 2019-07-01 4/A POAI Predictive Oncology Inc.
Stock Option
A - Award 42,194 42,194
2019-09-18 2019-07-01 4/A POAI Predictive Oncology Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 11,506 1,171,405 0.99
2019-08-22 2019-08-09 4/A SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 62,433 2,000,000 3.22 0.75 46,825 1,500,000
2019-08-22 2019-08-08 4/A SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 437,567 1,937,567 29.17 0.69 301,921 1,336,921
2019-08-16 2019-08-09 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 62,433 2,000,000 3.22 0.75 46,825 1,500,000
2019-08-16 2019-08-08 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 437,567 1,937,567 29.17 0.69 301,921 1,336,921
2019-08-15 2019-08-01 4 POAI Predictive Oncology Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 11,506 1,276,387 0.91
2019-08-15 2019-08-01 4 POAI Predictive Oncology Inc.
Stock Option
A - Award 51,282 1,264,481 4.23
2019-08-15 2019-07-01 4 POAI Predictive Oncology Inc.
Stock Option
A - Award 42,194 1,213,599 3.60
2019-07-02 2019-07-01 4 POAI Predictive Oncology Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 11,506 1,171,405 0.99
2019-06-04 2019-06-01 4 AIPT Precision Therapeutics Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 11,506 1,159,899 1.00
2019-05-28 2019-05-24 4 AIPT Precision Therapeutics Inc.
Common Stock
P - Purchase 48,332 244,298 24.66 0.55 26,689 134,901
2019-05-28 2019-05-23 4 AIPT Precision Therapeutics Inc.
Common Stock
P - Purchase 51,668 195,966 35.81 0.56 29,099 110,368
2019-05-24 2019-05-01 4 AIPT Precision Therapeutics Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 11,506 1,148,393 1.01
2019-05-24 2019-04-01 4 AIPT Precision Therapeutics Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 5,279 1,136,887 0.47
2019-05-24 2019-03-01 4 AIPT Precision Therapeutics Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 5,279 1,131,608 0.47
2019-05-24 2019-02-06 4 AIPT Precision Therapeutics Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 138,889 1,126,329 14.07
2019-05-24 2019-02-01 4 AIPT Precision Therapeutics Inc.
Third Amended and Restated Common Stock Purchase Warrant
J - Other 5,279 987,440 0.54
2019-05-24 2019-05-07 4/A SGLB SIGMA LABS, INC.
Warrants to purchase Common Stock
P - Purchase 200,000 200,000
2019-05-24 2019-05-07 4/A SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 400,000 400,000 1.40 560,000 560,000
2019-05-23 2019-05-07 4 SGLB SIGMA LABS, INC.
Warrants to purchase Common Stock
P - Purchase 200,000 200,000
2019-05-23 2019-05-07 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 400,000 400,000 1.40 560,000 560,000
2019-04-08 2019-04-04 4 AIPT Precision Therapeutics Inc.
Stock Options (right to buy)
A - Award 200,000 200,000
2019-04-02 2019-04-01 4 AIPT Precision Therapeutics Inc.
Amended and Restated Warrant to purchase common stock
J - Other 6,227 982,161 0.64
2019-03-04 2019-03-01 4 AIPT Precision Therapeutics Inc.
Amended and Restated Warrant to purchase common stock
J - Other 6,227 975,934 0.64
2019-02-05 2019-02-01 4 AIPT Precision Therapeutics Inc.
Amended and Restated Warrant to purchase common stock
J - Other 6,227 969,707 0.65
2019-01-17 2019-01-08 4 AIPT Precision Therapeutics Inc.
Amended and Restated Warrant to purchase common stock
P - Purchase 742,188 963,480 335.39
2019-01-17 2019-01-08 4 AIPT Precision Therapeutics Inc.
Common Stock
P - Purchase 78,125 144,298 118.06 0.64 50,000 92,351
2019-01-17 2019-01-02 4 AIPT Precision Therapeutics Inc.
Stock Options (right to buy)
A - Award 323,050 323,050
2018-12-10 2018-11-30 4 AIPT Precision Therapeutics Inc.
Warrant to purchase common stock
P - Purchase 221,292 221,292
2018-09-04 2018-08-29 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 88,993 1,500,000 6.31 1.02 90,773 1,530,000
2018-09-04 2018-08-28 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 7,361 1,411,007 0.52 1.03 7,582 1,453,337
2018-09-04 2018-08-27 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 8,063 1,403,646 0.58 1.02 8,224 1,431,719
2018-09-04 2018-08-24 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 99,756 1,395,583 7.70 1.03 102,749 1,437,450
2018-09-04 2018-08-23 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 57,083 1,295,827 4.61 1.03 58,795 1,334,702
2018-09-04 2018-08-22 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 3,600 1,238,744 0.29 1.02 3,672 1,263,519
2018-09-04 2018-08-21 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 106,753 1,235,144 9.46 0.99 105,685 1,222,793
2018-09-04 2018-08-20 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 65,374 1,128,391 6.15 0.98 64,067 1,105,823
2018-09-04 2018-08-17 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 36,411 1,063,017 3.55 0.97 35,319 1,031,126
2018-09-04 2018-08-16 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 26,606 1,026,606 2.66 0.88 23,413 903,413
2018-08-27 2018-08-01 4 AIPT Precision Therapeutics Inc.
Stock Options (right to buy)
A - Award 44,899 44,899
2018-08-08 2018-08-07 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 27,025 1,000,000 2.78 0.90 24,320 899,900
2018-08-08 2018-08-06 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 33,067 972,975 3.52 0.90 29,618 871,494
2018-08-08 2018-08-03 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 100 939,908 0.01 0.85 85 798,922
2018-08-08 2018-08-02 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 11,900 939,808 1.28 0.85 10,057 794,232
2018-08-08 2018-08-01 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 6,163 927,908 0.67 0.85 5,218 785,660
2018-08-08 2018-07-31 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 3,745 921,745 0.41 0.85 3,175 781,455
2018-08-08 2018-07-30 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 20,400 918,000 2.27 0.83 16,920 761,389
2018-08-08 2018-07-27 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 11,900 897,600 1.34 0.86 10,234 771,936
2018-08-08 2018-07-26 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 18,225 885,700 2.10 0.85 15,464 751,516
2018-08-08 2018-07-25 4 SGLB SIGMA LABS, INC.
Common Stock
P - Purchase 11,572 867,475 1.35 0.86 9,946 745,595
2018-08-08 3 SGLB SIGMA LABS, INC.
Common Stock
1,711,806
2018-08-08 3 SGLB SIGMA LABS, INC.
Common Stock
1,711,806
2018-08-08 3 SGLB SIGMA LABS, INC.
Common Stock
1,711,806
2018-07-02 2018-07-02 4 AIPT Precision Therapeutics Inc.
Stock Options (right to buy)
A - Award 121,682 121,682
2018-01-04 2018-01-02 4 SKLN Skyline Medical Inc.
Stock Options (right to buy)
A - Award 141,753 141,753
2017-11-14 2017-11-10 4 SKLN Skyline Medical Inc.
Stock Options (right to buy)
A - Award 28,316 28,316
2017-06-26 2017-06-22 4 SKLN Skyline Medical Inc.
Stock Options (right to buy)
A - Award 376,886 376,886
2017-04-06 2017-03-31 4 SKLN Skyline Medical Inc.
Stock Options (right to buy)
A - Award 2,381 2,381
2017-01-27 2017-01-26 4 SKLN Skyline Medical Inc.
Stock Options (right to buy)
A - Award 1,786 1,786
2017-01-27 2017-01-26 4 SKLN Skyline Medical Inc.
Stock Options (right to buy)
A - Award 7,143 7,143
2016-07-07 2016-06-30 4 SKLN Skyline Medical Inc.
Stock Options (right to buy)
A - Award 33,334 33,334
2016-04-05 2016-03-31 4 SKLN Skyline Medical Inc.
Stock Options (right to buy)
A - Award 14,706 14,706
2016-03-30 3 SKLN Skyline Medical Inc.
Common Stock
3,308,624
2016-03-30 3 SKLN Skyline Medical Inc.
Common Stock
3,308,624
2013-04-01 3 BIOR BioDrain Medical, Inc.
Common Stock
7,140,904
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)